Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New endothelin antagonists from Zeneca

Jan. 22, 1997

New agents for treating encephalopathies from Takeda

Jan. 22, 1997

New antimigraine drug candidates from Lilly

Jan. 22, 1997

Yamanouchi reports 5-HT3 agonists for GI indications

Jan. 22, 1997

Histamine H3 receptor antagonists in development at Gliatech

Jan. 22, 1997

GI motility stimulants reported by Janssen

Jan. 22, 1997

New 5-HT1A receptor ligands reported by Bayer

Jan. 21, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Sumitomo reports novel hCNTF variant

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...